MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
| Current Price | ₹900.15 |
|---|---|
| Market Cap | ₹10,807 Cr |
| Sector | Consumer Staples > Consumer Staples Distribution and Retail > Consumer Staples Distribution and Retail |
| Sub-Industry | Drug Retail > Drug Stores and Pharmacies |
| P/E Ratio | 49.2 |
| Return on Equity | 11.82% |
| 52-Week Range | ₹732.00 – ₹1,022.20 |
| Beta (1Y) | -0.08 |
1. Retail-98.1% 2. Diagnostic Services-1.9% 3. Others-0%
Medplus Health Services Limited is trading at ₹900.15, with a market capitalisation of ₹10,807 Cr.
Medplus Health Services Limited operates in the Consumer Staples > Consumer Staples Distribution and Retail > Consumer Staples Distribution and Retail space (Drug Retail > Drug Stores and Pharmacies).
Medplus Health Services Limited has a P/E of 49.2 and a return on equity of 11.82%.